Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06004440 · ClinicalTrials.gov registry record

Real World Registry for Use of the Ion Endoluminal System

A clinical trial of Lung Cancer and Neoplasms, sponsored by Intuitive Surgical.

Recruiting
Registry status
3,000
Enrollment target
16
Study locations

NCT06004440 is a study of Lung Cancer and Neoplasms that is actively recruiting participants, run by Intuitive Surgical. The registered enrollment target is 3,000 participants, above the 928-participant average among 409 other Lung Cancer trials with a reported enrollment target (223% higher). The trial reports 16 study locations across 13 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06004440, a study of Lung Cancer and Neoplasms, is actively recruiting participants, sponsored by Intuitive Surgical.

RECRUITING
Registry status
3,000 participants
Enrollment target
16
Study locations

Study Summary

The primary objective of this study is to evaluate the performance of the Ion Endoluminal System with real-world use for pulmonary lesion localization or biopsy.

Conditions Studied

Lung Cancer Neoplasms Lung Diseases Lung Neoplasms Neoplasms by Site Respiratory Tract Diseases Multiple Pulmonary Nodules Thoracic Neoplasms Respiratory Tract Neoplasms

Interventions

  • DEVICE Ion Endoluminal System

Study Locations (16)

North Carolina

  • Atrium Health of the Carolinas - Charlotte
  • Cone Health Moses Cone Memorial Hospital - Greensboro
  • FirstHealth Moore Regional Hospital - Pinehurst

Illinois

  • Ascension Alexian Brothers - Elk Grove Village
  • Blessing Hospital - Quincy

Florida

  • Orlando Health Orlando Regional Medical Center - Orlando

Kansas

  • Kansas University Medical Center - Kansas City

Louisiana

  • Tulane University - New Orleans

Michigan

  • Henry Ford Hospital - Detroit

Minnesota

  • Mayo Clinic - Rochester

New York

  • Mercy Hospital of Buffalo - Buffalo

Trial Details

FieldValue
Enrollment Target 3,000 participants
Start Date 2023-09-21
Est. Completion 2030-08

Sponsor

Intuitive Surgical

40 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06004440

The ClinicalTrials.gov registry entry for NCT06004440 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 3,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 928-participant average among 409 other Lung Cancer trials with a reported enrollment target (223% higher). The listed sponsor is Intuitive Surgical, which has 40 total studies on file at ClinicalTrials.gov.

The record links to 9 conditions, with Lung Cancer appearing as the primary indexed condition, and to 1 intervention - of which Ion Endoluminal System is the first listed.

NCT06004440 reports 16 study locations spanning 13 distinct geographic areas - top geographies include North Carolina, Illinois, Florida.

Frequently Asked Questions

What is clinical trial NCT06004440 about?

NCT06004440 is a clinical study titled "Real World Registry for Use of the Ion Endoluminal System". The primary objective of this study is to evaluate the performance of the Ion Endoluminal System with real-world use for pulmonary lesion localization or biopsy.

What is the current status of trial NCT06004440?

This trial is currently recruiting. The enrollment target is 3,000 participants. The study started on 2023-09-21. Estimated completion is 2030-08.

What conditions does trial NCT06004440 study?

This clinical trial studies the following conditions: Lung Cancer, Neoplasms, Lung Diseases, Lung Neoplasms, Neoplasms by Site.

What interventions are being tested in trial NCT06004440?

The interventions under investigation include: Ion Endoluminal System (DEVICE).

Who is sponsoring clinical trial NCT06004440?

This trial is sponsored by Intuitive Surgical, which has 40 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06004440 being conducted?

This trial has 16 study locations across Florida, Illinois, Kansas, Louisiana, Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Lung Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Lung Cancer

All registered trials for this condition

Neoplasms

All registered trials for this condition

Florida

All trials with a study site in Florida

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.